SCHEMBL8834183

SCHEMBL8834183

Cc1ccc(Nc2cc3c(cc2Nc2ccc(C)cc2)C(=O)NC3=O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 1.00
KMT2A Q03164 6/20 0.69
SRC P12931 5/20 0.69
MEN1 O00255 5/20 0.69
PRKCB P05771 4/20 0.69
TDP1 Q9NUW8 4/20 0.69
PRKD3 O94806 3/20 0.69
PRKCG P05129 3/20 0.69
PRKCA P17252 3/20 0.69
PRKCH P24723 3/20 0.69
PRKCI P41743 3/20 0.69
PRKCE Q02156 3/20 0.69
PRKCQ Q04759 3/20 0.69
PRKCZ Q05513 3/20 0.69
PRKCD Q05655 3/20 0.69
PRKD1 Q15139 3/20 0.69
MAPT P10636 3/20 0.69
ABL1 P00519 1/20 0.69
ABL2 P42684 1/20 0.69
KDM4E B2RXH2 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8834327 0.81 EGFR (1.00) EGFRKMT2ASRCMEN1PRKCB
SCHEMBL8834514 0.81 EGFR (0.69) EGFRKMT2ASRCMEN1PRKCB
SCHEMBL8834755 0.81 EGFR (0.69) EGFRKMT2ASRCMEN1PRKCB
Cgp-53353 SCHEMBL230492 0.81 EGFR (1.00) EGFRKMT2ASRCMEN1PRKCB
Cgp-53353 SCHEMBL29766901 0.81 EGFR (1.00) EGFRKMT2ASRCMEN1PRKCB
SCHEMBL8834275 0.81 EGFR (0.69) EGFRKMT2ASRCMEN1PRKCB
Daph SCHEMBL11017 0.81 EGFR (1.00) EGFRKMT2ASRCMEN1PRKCB
SCHEMBL8835045 0.81 EGFR (0.70) EGFRKMT2ASRCMEN1PRKCB
SCHEMBL8835027 0.81 EGFR (0.68) EGFRKMT2ASRCMEN1PRKCB
SCHEMBL5814108 0.81 EGFR (0.88) EGFRKMT2ASRCMEN1PRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed
US-5663336-A IMIDATION OF DIAMINOPHTHALIC ACID TO FORM KINASE INHIBITORS AS ANTITUMOR AGENTS CIBA-GEIGY CORPORATION (US) 1997-09-02 US disclosed
US-5491144-A KINASE INHIBITORS, ANTITUMOR AGENTS CIBA-GEIGY CORPORATION (US) 1996-02-13 US disclosed
EP-0516588-B1 Substituted diaminophtalimides and analogues CIBA GEIGY AG (CH) 1994-07-13 EP disclosed
EP-0600832-A1 Derivatives of diamino benzoic and diamino phthalic acid und their use as protein linase inhibitors CIBA-GEIGY AG (CH) 1994-06-08 EP disclosed
EP-0516588-A1 Substituted diaminophtalimides and analogues CIBA-GEIGY AG (CH) 1992-12-02 EP disclosed